Evaluating the impact of HIV pre-exposure prophylaxis on pregnancy, infant, and maternal health outcomes in Malawi: PrIMO study protocol

被引:1
作者
Saidi, Friday [1 ,2 ,3 ]
Shah, Sanya [1 ,4 ]
Squibb, Madeleine [5 ]
Chinula, Lameck [1 ,2 ,3 ]
Nakanga, Charity [1 ]
Mvalo, Tisungane [1 ,6 ]
Matoga, Mitch [1 ]
Bula, Agatha K. [1 ]
Chagomerana, Maganizo B. [1 ,7 ]
Kamanga, Funny [1 ]
Kumwenda, Wiza [1 ]
Mkochi, Tawonga [1 ]
Masiye, Gladwell [1 ]
Moya, Ida [1 ]
Herce, Michael E. [7 ]
Rutstein, Sarah E. [8 ]
Thonyiwa, Virginia [9 ]
Nyirenda, Rose K. [10 ]
Mwapasa, Victor [11 ]
Hoffman, Irving [1 ,7 ]
Hosseinipour, Mina C. [1 ,7 ,8 ]
机构
[1] Univ North Carolina UNC, Project Malawi, P Bag A-104, Lilongwe, Malawi
[2] Univ North Carolina Chapel Hill, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA
[3] Kamuzu Univ Hlth Sci, Dept Obstet & Gynecol, Lilongwe, Malawi
[4] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA
[5] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[6] Univ North Carolina Chapel Hill, Sch Med, Dept Pediat, Chapel Hill, NC USA
[7] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA
[8] Univ North Carolina Chapel Hill, Sch Med, Dept Med, Chapel Hill, NC 27599 USA
[9] Malawi Natl AIDS Commiss, Lilongwe, Malawi
[10] Minist Hlth Malawi, Dept HIV STI & Viral Hepatitis, Lilongwe, Malawi
[11] Kamuzu Univ Hlth Sci, Sch Global & Publ Hlth, Blantyre, Malawi
关键词
HIV prevention; Pre-exposure prophylaxis; Cabotegravir; Birth outcomes; Infant; and maternal health outcomes; BREAST-FEEDING WOMEN; RISK SCORING TOOL; PREVENTION;
D O I
10.1186/s12889-024-20029-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundIncident HIV during the perinatal period significantly impedes elimination of Mother-to-Child HIV Transmission (eMTCT) efforts. Pre-Exposure Prophylaxis (PrEP) effectively reduces HIV acquisition, and new agents like injectable Cabotegravir (CAB-LA) offer potential advantages for pregnant and breastfeeding women. The Pregnancy, Infant, and Maternal health Outcomes (PrIMO) study will compare rates of composite adverse pregnancy outcomes, and infant adverse events, growth and neurodevelopment between mother-infant dyads receiving CAB-LA and those receiving oral PrEP in Malawi.MethodsPrIMO is an observational cohort study involving: (1) the development of a PrEP Pregnancy Registry for longitudinal surveillance of pregnant women on PrEP in Malawi; and (2) the enrolment of a prospective safety cohort of 621 pregnant women initiating oral PrEP or CAB-LA and their subsequent infants. The registry will include all women continuing or initiating PrEP during pregnancy across targeted sites in Lilongwe and Blantyre districts. The safety cohort will enrol a subset of those women and their infants from Bwaila District Hospital in Lilongwe, Malawi. We hypothesize that CAB-LA's safety will be comparable to daily oral PrEP regarding adverse pregnancy outcomes, maternal/infant adverse events, and infant development. Participants in the cohort will choose either oral PrEP or CAB-LA and will be followed until 52 weeks post-delivery. Safety data will be collected from all mother-infant pairs and qualitative interviews will be conducted with a subset of purposively selected women (n = 50) to assess the acceptability of each PrEP modality.DiscussionThe PrIMO study will provide critical data on the safety of CAB-LA in pregnant and breastfeeding women and their infants. Results will guide clinical recommendations as the Malawi Ministry of Health prepares for the rollout of CAB-LA to this population. Evaluation of Registry implementation will inform its expansion to a nationwide safety monitoring system for PrEP use during pregnancy, with implications for similar systems in the region.Trial Registration numberNCT06158126. The study was prospectively registered (5 December 2023) in ClinicalTrials.gov.
引用
收藏
页数:11
相关论文
共 50 条
[41]   The Impact of HIV Pre-exposure Prophylaxis (PrEP) Use on the Sexual Health of Men Who Have Sex with Men: A Qualitative Study in Seattle, WA [J].
Collins, Shane P. ;
McMahan, Vanessa M. ;
Stekler, Joanne D. .
INTERNATIONAL JOURNAL OF SEXUAL HEALTH, 2017, 29 (01) :55-68
[42]   Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm [J].
Kansiime, Sheila ;
Hansen, Christian Holm ;
Bern, Henry ;
Fox, Julie ;
Dunn, David ;
Ruzagira, Eugene ;
Hayes, Richard ;
Mc Cormack, Sheena .
HIV RESEARCH & CLINICAL PRACTICE, 2025, 26 (01)
[43]   Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care [J].
Sonalkar, Sarita ;
McAllister, Arden ;
Kete, Corinne ;
Fishman, Jessica ;
Frarey, Alhambra ;
Short, William R. ;
Schreiber, Courtney A. ;
Teitelman, Anne .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 :S129-S133
[44]   Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines [J].
Wright, Edwina ;
Grulich, Andrew ;
Roy, Katy ;
Boyd, Mark ;
Cornelisse, Vincent ;
Russell, Darren ;
O'Donnell, Darryl ;
Whittaker, Bill ;
Crooks, Levinia ;
Zablotska, Iryna .
JOURNAL OF VIRUS ERADICATION, 2017, 3 (03) :168-184
[45]   Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis [J].
Erlwanger, Alison ;
Rocroi, Isabelle ;
Kirtley, Shona ;
Hemelaar, Joris .
ECLINICALMEDICINE, 2024, 70
[46]   Human Resource Challenges to Integrating HIV Pre-Exposure Prophylaxis (PrEP) into the Public Health System in Kenya: A Qualitative Study [J].
Mack, Natasha ;
Wong, Christina ;
McKenna, Kevin ;
Lemons, Ansley ;
Odhiambo, Jacob ;
Agot, Kawango .
AFRICAN JOURNAL OF REPRODUCTIVE HEALTH, 2015, 19 (01) :54-62
[47]   Online Navigation for Pre-Exposure Prophylaxis via PleasePrEPMe Chat for HIV Prevention: Protocol for a Development and Use Study [J].
Weber, Shannon ;
Lazar, Laura ;
McCord, Alan ;
Romero, Charlie ;
Tan, Judy .
JMIR RESEARCH PROTOCOLS, 2020, 9 (09)
[48]   Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California [J].
Hunter, Lauren A. ;
Packel, Laura J. ;
Chitle, Pooja ;
Beltran, Raiza M. ;
Rafie, Sally ;
De Martini, Loriann ;
Dong, Betty ;
Harris, Orlando ;
Holloway, Ian W. ;
Ochoa, Ayako Miyashita ;
McCoy, Sandra, I .
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11)
[49]   Advantages and limits of remote consultations for HIV pre-exposure prophylaxis health pathway: ePrEP qualitative study [J].
Faussat, Cathie ;
Bonnin, Alicia ;
Hilt, Daniel ;
Riviere-Da Silva, Fabien ;
Baissin, Christine ;
Michels, David ;
Gras, Guillaume ;
Leclerc, Celine ;
Aumond, Catherine ;
Grammatico-Guillon, Leslie .
JOURNAL OF EPIDEMIOLOGY AND POPULATION HEALTH, 2024, 72 (02)
[50]   Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States [J].
Schneider, John A. ;
Bouris, Alida ;
Smith, Dawn K. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (01) :E30-E32